EP2100614
Mótefni gegn PDGFR-alfa til notkunar í meðhöndluninni á æxlum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.6.2006EP published:
9.10.2013EP application number:
09075103.3
EP translation filed:
4.12.2013Grant published:
15.12.2013EPO information:
European Patent Register
Max expiry date:
18.6.2026Expiry date:
18.6.2026
Title:
Antibody against PDGFR-alpha for use in the treatment of tumours
Timeline
Owner
Name:
ImClone LLCAddress:
450 East 29th Street, 12th Floor, 10016, New York, NY, US
Inventor
Name:
Loizos, NickAddress:
Staten Island, NY, US
Name:
Huber, JimAddress:
Scotch Plains, NJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
691920 PDate:
17.6.2005Country:
US
Supplementary protection
SPC number:
SPC189
Classification
Categories:
A61K 38/17, A61K 39/395, C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 13.5.2014
Expires: 18.6.2015
Payer: Örn Þór, slf.
Number: 10
Paid: 12.5.2015
Expires: 18.6.2016
Payer: Örn Þór, slf.
Number: 11
Paid: 11.5.2016
Expires: 18.6.2017
Payer: Örn Þór, slf.
Number: 12
Paid: 15.5.2017
Expires: 18.6.2018
Payer: Örn Þór, slf.
Number: 13
Paid: 9.5.2018
Expires: 18.6.2019
Payer: Örn Þór, slf.
Number: 14
Paid: 14.5.2019
Expires: 18.6.2020
Payer: Örn Þór, slf.
Number: 15
Paid: 15.5.2020
Expires: 18.6.2021
Payer: Örn Þór slf.
Number: 16
Paid: 19.5.2021
Expires: 18.6.2022
Payer: Patice ehf.
Number: 17
Paid: 18.5.2022
Expires: 18.6.2023
Payer: Patice ehf.
Number: 18
Paid: 24.5.2023
Expires: 18.6.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 23.5.2024
Expires: 18.6.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 12.6.2025
Expires: 18.6.2026
Payer: Árnason Faktor ehf.